NRCME Hypertension Guidelines 3 — Questions and Answers
Question 1: A driver with documented white-coat hypertension consistently shows BP of 155/95 in the clinic but 125/80 on ambulatory monitoring. What should the CME do?
- Consider ambulatory or home readings in the clinical evaluation (Correct answer)
- Certify at full 2 years without further review
- Disqualify based on office reading alone
- Refer to cardiology and withhold all certification
Correct answer: Consider ambulatory or home readings in the clinical evaluation
CMEs may consider validated ambulatory or home BP monitoring data to differentiate white-coat hypertension from true sustained hypertension in clinical decision-making.
Question 2: Under FMCSA hypertension guidelines, a driver with BP controlled to 130/82 mmHg on medication who was previously Stage 2 should receive a certificate of:
- Up to 12 months to ensure ongoing control (Correct answer)
- 24 months with no restriction
- 6 months only
- No certification until off medication
Correct answer: Up to 12 months to ensure ongoing control
A driver previously identified as Stage 2 hypertension who achieves controlled BP on medication may be certified for up to one year to confirm sustained control.
Question 3: Which of the following cardiovascular complications of hypertension would most directly disqualify a commercial driver?
- Hypertensive retinopathy with visual field defects (Correct answer)
- Mild left ventricular hypertrophy without symptoms
- Microalbuminuria without renal impairment
- Aortic stiffness without symptoms
Correct answer: Hypertensive retinopathy with visual field defects
Hypertensive retinopathy causing visual field defects directly impairs vision, which is a disqualifying condition under FMCSA standards for commercial drivers.
Question 4: A driver reports taking amlodipine for hypertension and notes ankle swelling. What is the most important safety consideration for the CME?
- Confirm the swelling is not from cardiac or renal disease before certifying (Correct answer)
- Immediately disqualify the driver
- Ignore the side effect as it is cosmetic only
- Switch the medication before certifying
Correct answer: Confirm the swelling is not from cardiac or renal disease before certifying
Peripheral edema from amlodipine (calcium channel blocker) is usually benign, but the CME must rule out heart failure or renal disease, which may affect driver fitness.
Question 5: How many separate BP measurements should a CME take before documenting the final reading, per best clinical practice?
- Two readings at least 1 minute apart, using the average (Correct answer)
- One reading is sufficient
- Three readings averaged over three separate days
- Five readings on the same day
Correct answer: Two readings at least 1 minute apart, using the average
Best practice is to take at least two readings separated by at least one minute and use the average to reduce measurement variability.
Question 6: A driver's BP is 158/96 mmHg at the start of the exam. The CME should:
- Allow the driver to rest and remeasure before making the final determination (Correct answer)
- Immediately issue a Stage 2 certificate
- Disqualify the driver outright
- Certify at 2 years with a note
Correct answer: Allow the driver to rest and remeasure before making the final determination
Allowing the driver to rest and repeating the measurement reduces the likelihood of a falsely elevated reading due to anxiety or physical exertion.
Question 7: Which condition, often co-existing with hypertension, independently requires the CME to consider cardiovascular risk when certifying a commercial driver?
- Type 2 diabetes mellitus (Correct answer)
- Mild anemia
- Seasonal allergies
- Osteoarthritis of the knee
Correct answer: Type 2 diabetes mellitus
Type 2 diabetes is a major cardiovascular risk factor that frequently co-exists with hypertension and must be evaluated independently and together for overall cardiovascular fitness to drive.
NRCME Hypertension Guidelines 3
A driver with documented white-coat hypertension consistently shows BP of 155/95 in the clinic but 125/80 on ambulatory monitoring.
What should the CME do?